Stock listing
CPHI Stock Price, News, Filings & Events — China Pharma Holdings, Inc.
Selected listing: CPHI · AMEX · USD · US
This page tracks China Pharma Holdings, Inc.'s CPHI:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CPHI:AMEX. CPHI:AMEX is the stock-level entry point for investors researching China Pharma Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. China Pharma Holdings, Inc. (CPHI) is a public company operating in the American market, with a market capitalization of approximately $44.6 million. The company focuses on the pharmaceutical industry, providing various products and services. As a publicly traded entity, CPHI is subject to regulatory requirements and market dynamics.
- Ticker
- CPHI:AMEX
- Asset type
- Stock
- Market cap
- $32.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AMEX
- Currency
- USD
China Pharma Holdings, Inc. CPHI:AMEX stock context
This page tracks China Pharma Holdings, Inc.'s CPHI:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CPHI:AMEX. CPHI:AMEX is the stock-level entry point for investors researching China Pharma Holdings, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. China Pharma Holdings, Inc. (CPHI) is a public company operating in the American market, with a market capitalization of approximately $44.6 million. The company focuses on the pharmaceutical industry, providing various products and services. As a publicly traded entity, CPHI is subject to regulatory requirements and market dynamics.
Latest news from China Pharma Holdings, Inc.
China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering
July 23, 2026
China Pharma Announces Pricing of $5 Million Registered Direct Offering
July 22, 2026
China Pharma : Securities Purchase Agreement Form 8 K
December 26, 2024
China Pharma : Announces the Entry of “At The Market” Equity Offering Form 8 K
December 13, 2024
CHINA PHARMA HOLDINGS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
April 20, 2023
Research China Pharma Holdings, Inc.
China Pharma Holdings, Inc. investor report
Review AI stock analysis and investor report context for CPHI:AMEX.
China Pharma Holdings, Inc. company profile
View the public company page for China Pharma Holdings, Inc. on 6ix.
China Pharma Holdings, Inc. news
Read company news and market updates connected to China Pharma Holdings, Inc..
China Pharma Holdings, Inc. investor events
Find investor webinars, events, and replay context for China Pharma Holdings, Inc..
Alternate listings
CPHI:BOATS
US · USD
Alternate listing for China Pharma Holdings, Inc.; the primary context on this page is CPHI:AMEX.
XQJ0:GETTEX
DE · EUR
Alternate listing for China Pharma Holdings, Inc.; the primary context on this page is CPHI:AMEX.
XQJ0:MUN
DE · EUR
Alternate listing for China Pharma Holdings, Inc.; the primary context on this page is CPHI:AMEX.